renflexis

Frequently asked questions

What does Renflexis treat?

Renflexis (Infliximab-Abda) may be used to treat rheumatoid arthritis, ulcerative colitis, crohn disease, ankylosing spondylitis, psoriatic arthritis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Renflexis?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Renflexis. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Renflexis?

Renflexis is marketed by Samsung Bioepis Co Ltd. You can see Samsung Bioepis Co Ltd's full profile, rating, and other products on pharmaranks.

Is Renflexis a brand-name or generic drug?

Renflexis is a brand-name product with the active ingredient Infliximab-Abda.

Is Renflexis available over the counter?

No. Renflexis is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Renflexis come in?

Renflexis is currently marketed as injectable, per the FDA's National Drug Code Directory.

Is Renflexis FDA-registered?

Renflexis is on record with the U.S. FDA under application number BLA761054. You can verify this on its official FDA label.